Clin2
NCT07656688Possibly a fitRecruiting

Finding the best dose for a dry eye treatment

Dry Eye Disease (DED)

Part of Eyes & vision clinical trials.

This trial tests different doses of a new eye drop (HUC1-394) to see which dose works best for people with moderate to severe dry eye disease. You may qualify if your dry eye symptoms have lasted at least 3 months and you have low tear production along with other signs of dry eye.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
150 people
Ages
19 years and older
Study type
Interventional

Who can take part

  • You are 19 years or older
  • You have had dry eye symptoms (like stinging, burning, or blurry vision) for at least 3 months
  • In at least one eye, your tear production is low (Schirmer test between 1 and 10 mm in 5 minutes) and your tear film breaks up quickly (less than 7 seconds)
  • You have a certain level of corneal damage (TCSS score of 4 or more on a 0–15 scale)
  • Your dry eye symptoms score (OSDI) is 23 or higher on a 0–100 scale, meaning moderate to severe discomfort

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07503886Recruiting· Phase 2
Study of an eye drop for dry eye disease

This trial tests a new eye drop called DFL24498 to see if it helps people with dry eye disease. You may qualify if your dry eye is moderate to severe and other treatments haven't worked well for you.

Chandler, Arizona
NCT06633471Not yet recruiting· Early Phase 1
Evaluating a new artificial tear for dry eye disease

This study tests a new eye drop formula to see if it safely improves dry eye symptoms. It may be a good option if you have been diagnosed with dry eye and have limited tear production.

Bridgetown
NCT07068958Not yet recruiting· Phase 2
A study testing a new eye drop for dry eye

This trial tests a new eye drop called RCI001 to see if it works better than a placebo for people with dry eye. You may be able to join if you have had dry eye for at least 6 months and have certain signs of dry eye during exams.

NCT07369375Not yet recruiting
Testing New Eye Drops for Dry Eye Disease

This study tests new eye drops for people with mild to moderate dry eye disease. It will check how well the drops work and if they are safe over time.

NCT07745062Recruiting· Phase 4
Comparing two eye drops for mild to moderate dry eye

This study tests two types of preservative-free eye drops to see which is more effective for people with mild to moderate dry eye disease. You will use one of the drops as directed, and the study will monitor your symptoms and eye health over time.

La Jolla, California
NCT07732010Recruiting· Phase 4
Tryptophan for dry eye disease

This trial tests whether a dietary supplement called TRYPTYR can improve dry eye symptoms. You may qualify if you have moderate dry eye with certain signs, like short tear breakup time and staining on your eye surface.

New York, New York

Hear when a new Dry Eye Disease (DED) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.